serw-MX  [xml]  
 


    
 DeCS Categories

A11 Cells .
A11.436 Epithelial Cells .
A11.436.265 Chromatophores .
A11.436.265.531 Melanophores .
A11.436.613 Melanocytes .
C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.465 Neoplasms, Germ Cell and Embryonal .
C04.557.465.625 Neuroectodermal Tumors .
C04.557.465.625.650 Neuroendocrine Tumors .
C04.557.465.625.650.510 Melanoma .
C04.557.580 Neoplasms, Nerve Tissue .
C04.557.580.625 Neuroectodermal Tumors .
C04.557.580.625.650 Neuroendocrine Tumors .
C04.557.580.625.650.510 Melanoma .
C04.557.665 Nevi and Melanomas .
C04.557.665.510 Melanoma .
C17 Skin and Connective Tissue Diseases .
C17.800 Skin Diseases .
C17.800.621 Pigmentation Disorders .
C17.800.621.430 Hyperpigmentation .
C17.800.621.430.530 Melanosis .
D02 Organic Chemicals .
D02.092 Amines .
D02.092.311 Catecholamines .
D02.092.311.200 Dihydroxyphenylalanine .
D02.092.311.200.180 Cysteinyldopa .
D02.886 Sulfur Compounds .
D02.886.030 Amino Acids, Sulfur .
D02.886.030.230 Cysteine .
D02.886.030.230.330 Cysteinyldopa .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.699 Peptide Hormones .
D06.472.699.327 Hypothalamic Hormones .
D06.472.699.327.935 Pro-Opiomelanocortin .
D06.472.699.327.935.531 Melanocortins .
D06.472.699.327.935.531.750 Melanocyte-Stimulating Hormones .
D06.472.699.631 Pituitary Hormones .
D06.472.699.631.525 Pituitary Hormones, Anterior .
D06.472.699.631.525.600 Pro-Opiomelanocortin .
D06.472.699.631.525.600.531 Melanocortins .
D06.472.699.631.525.600.531.750 Melanocyte-Stimulating Hormones .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.072 Amino Acids, Cyclic .
D12.125.072.050 Amino Acids, Aromatic .
D12.125.072.050.685 Phenylalanine .
D12.125.072.050.685.400 Dihydroxyphenylalanine .
D12.125.072.050.685.400.180 Cysteinyldopa .
D12.125.072.050.875 Tyrosine .
D12.125.072.050.875.130 Dihydroxyphenylalanine .
D12.125.072.050.875.130.180 Cysteinyldopa .
D12.125.072.050.875.379 Melanins .
D12.125.166 Amino Acids, Sulfur .
D12.125.166.230 Cysteine .
D12.125.166.230.330 Cysteinyldopa .
D12.644 Peptides .
D12.644.400 Neuropeptides .
D12.644.400.400 Hypothalamic Hormones .
D12.644.400.400.935 Pro-Opiomelanocortin .
D12.644.400.400.935.531 Melanocortins .
D12.644.400.400.935.531.750 Melanocyte-Stimulating Hormones .
D12.644.400.460 Melanocyte-Stimulating Hormones .
D12.644.548 Peptide Hormones .
D12.644.548.365 Hypothalamic Hormones .
D12.644.548.365.935 Pro-Opiomelanocortin .
D12.644.548.365.935.531 Melanocortins .
D12.644.548.365.935.531.750 Melanocyte-Stimulating Hormones .
D12.644.548.691 Pituitary Hormones .
D12.644.548.691.525 Pituitary Hormones, Anterior .
D12.644.548.691.525.690 Pro-Opiomelanocortin .
D12.644.548.691.525.690.531 Melanocortins .
D12.644.548.691.525.690.531.750 Melanocyte-Stimulating Hormones .
D12.776 Proteins .
D12.776.624 Neoplasm Proteins .
D12.776.624.301 Melanoma-Specific Antigens .
D12.776.624.301.750 MART-1 Antigen .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.650 Neuropeptides .
D12.776.631.650.405 Hypothalamic Hormones .
D12.776.631.650.405.935 Pro-Opiomelanocortin .
D12.776.631.650.405.935.531 Melanocortins .
D12.776.631.650.405.935.531.750 Melanocyte-Stimulating Hormones .
D12.776.631.650.460 Melanocyte-Stimulating Hormones .
D23 Biological Factors .
D23.050 Antigens .
D23.050.285 Antigens, Neoplasm .
D23.050.285.439 Melanoma-Specific Antigens .
D23.050.285.439.750 MART-1 Antigen .
D23.767 Pigments, Biological .
D23.767.620 Melanins .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Melanocytes .
Melanocyte .
Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES. .
1.00
 
Melanocyte-Stimulating Hormones .
MSH (Melanocyte-Stimulating Hormones) .
Melanophore-Stimulating Hormone .
Melanocyte Stimulating Hormones .
Melanophore Stimulating Hormone .
MSH 13139 .
Melanotropin .
MSH-Releasing Hormone .
Melanocyte-Stimulating Hormone Releasing Hormone .
INTERMEDINS .
Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. .
0.52
 
Melanophores .
Melanophore .
Chromatophores (large pigment cells of fish, amphibia, reptiles and many invertebrates) which contain melanin. Short term color changes are brought about by an active redistribution of the melanophores pigment containing organelles (MELANOSOMES). Mammals do not have melanophores; however they have retained smaller pigment cells known as MELANOCYTES. .
0.50
 
Melanins .
Allomelanins .
Melanin .
Phaeomelanins .
Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. .
0.44
 
Cysteinyldopa .
5-S-Cysteinyldopa .
5 S Cysteinyldopa .
Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells. .
0.43
 
Melanoma .
Malignant Melanomas .
Melanoma, Malignant .
Melanomas .
Melanomas, Malignant .
Malignant Melanoma .
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) .
0.43
 
MART-1 Antigen .
MART1 Antigen .
Melan-A .
MelanA .
Antigen, MART-1 .
Antigen, MART1 .
Antigens, MART1 .
MART 1 Antigen .
Melan A .
Melanoma Antigen Recognized by T Cells 1 .
MART1 Antigens .
Melanoma Antigen Recognized by T-Cells 1 .
A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells. .
0.42
 
Melanosis .
Chloasmas .
Freckle .
Melanoses .
Melasmas .
Chloasma .
Melasma .
Freckles .
Melanism .
Disorders of increased melanin pigmentation that develop without preceding inflammatory disease. .
0.41